Brady Johnson Cidara Therapeutics, Inc. (CDTX) insider trading activity

CDTX Quotes by TradingView

Brady Johnson is Vice President, Finance of Cidara Therapeutics, Inc.. Currently has a direct ownership of 59,366 shares of CDTX, which is worth approximately $794,910. The most recent transaction as insider was on Mar 31, 2022, when has been sold 10,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 59.4K
0% 3M change
0% 12M change
Total Value Held $794,910

Brady Johnson Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 31 2022
BUY
Grant, award, or other acquisition
-
10,000 Added 14.42%
59,366 Common Stock
Mar 21 2022
SELL
Open market or private sale
$530 $0.81 p/Share
654 Reduced 1.31%
49,366 Common Stock
Mar 11 2022
SELL
Open market or private sale
$671 $0.71 p/Share
945 Reduced 1.85%
50,020 Common Stock
Jan 05 2022
SELL
Open market or private sale
$520 $1.25 p/Share
416 Reduced 0.81%
50,965 Common Stock
Dec 29 2021
BUY
Exercise of conversion of derivative security
-
262 Added 0.51%
51,381 Common Stock
Sep 30 2021
BUY
Grant, award, or other acquisition
-
20,750 Added 30.54%
47,199 Common Stock
BJ

Brady Johnson

Vice President, Finance
San Diego, CA

Track Institutional and Insider Activities on CDTX

Follow Cidara Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDTX shares.

Notify only if

Insider Trading

Get notified when an Cidara Therapeutics, Inc. insider buys or sells CDTX shares.

Notify only if

News

Receive news related to Cidara Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CDTX